Nu-Med Plus (NUMD) Current Leases (2019)
Nu-Med Plus (NUMD) reported Current Leases of $5039.0 for Q1 2019.
Nu-Med Plus (NUMD) Current Leases (2019) Analysis & Trends
Nu-Med Plus (NUMD) has 1 years of Current Leases data on file, last reported at $5039.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.21 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.52 Bn | 125.64 Bn | 3.81 Bn | - |
| 3 | Medtronic | 108.06 Bn | 98.84 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 68.04 Bn | 66.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn | 24.30 Mn |
| 6 | GE HealthCare Technologies | 28.45 Bn | 26.17 Bn | 1.98 Bn | - |
| 7 | Dexcom | 28.41 Bn | 27.29 Bn | 750.30 Mn | 20.50 Mn |
| 8 | Smith & Nephew | 26.88 Bn | 26.30 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn | - |
| 10 | Nu-Med Plus | 1.67 Mn | 1.67 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 5,039.00 |